Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2015

Net Loss Per Share

Summary of potentially dilutive securities outstanding excluded from the computation of diluted weighted-average shares outstanding

The following potentially dilutive securities outstanding, prior to the use of the treasury stock method, have been excluded from the computation of diluted weighted-average shares outstanding for the years ended December 31, 2015 and 2014, as they would be anti-dilutive.In addition, Second Installment Shares issuable to former Bioceros shareholders with a value of $5,000 to be issued in March 2016 have been excluded from the computation of basic and diluted weighted-average shares outstanding for the year ended December 31, 2015 (Note 5).

	As of December 31,
	2015	2014
Options to purchase common stock	3,613,427	1,652,882
Settlement of loan agreement	248,093	248,093
Nonvested restricted stock units	124,442	—
Warrants to purchase common stock	92,892	93,040
Employee stock purchase plan	2,871	—
Nonvested restricted stock awards	—	13,259